Sermonix Pharmaceuticals

📍 Columbus, United States🗓 Founded 2014👥 13 employees💰 Last funded Nov 2021
Pharmaceutical Manufacturing🌐 sermonixpharma.com
Website LinkedIn
Sermonix Pharmaceuticals, founded by David Portman, MD—a leading clinical researcher and expert in women’s health—focuses on developing targeted therapeutics to treat ESR1-mutated metastatic breast and gynecological cancers. Our ELAINE Studies are evaluating an investigational oral drug, lasofoxifene, a novel targeted endocrine agent, in women and men with locally advanced or metastatic estrogen receptor-positive/human epidermal growth factor 2-negative (ER+/HER2-) breast cancer harboring an ESR1 mutation(s).
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sermonix Pharmaceuticals?
Sermonix Pharmaceuticals has 1 investors on record on gritt.io and 1 late-stage investors.
When did Sermonix Pharmaceuticals last raise funding?
The most recent investment in Sermonix Pharmaceuticals recorded on gritt.io was in November 2021.
When was Sermonix Pharmaceuticals founded?
Sermonix Pharmaceuticals was founded in 2014.
What industry is Sermonix Pharmaceuticals in?
Sermonix Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Sermonix Pharmaceuticals based?
Sermonix Pharmaceuticals is headquartered in Columbus, United States.